Hormone · Synthetic gonadotrophin-releasing hormone receptor antagonist
Detirelix
Also known as —
A GnRH-derived antagonist studied in pituitary assays and animal models of reproductive endocrine feedback.
- Length
- 10 amino acids
- Half-life
- Not well characterised
- Mechanism
- Detirelix competitively blocks GnRHR, preventing GnRH from activating pituitary gonadotroph signalling. Its antagonism reduces GnRH-driven secretion of luteinising hormone and follicle-stimulating hormone in responsive experimental systems.
- Studied in
- Pituitary assays and animal reproductive-endocrine models, including non-human primate studies, have examined Detirelix-mediated inhibition of GnRH-dependent gonadotrophin secretion.
About Detirelix
Detirelix emerged from research on modified GnRH peptides designed to prevent receptor activation rather than mimic the native hormone. It retains a ten-residue backbone but incorporates non-native side chains and altered amino-acid stereochemistry. This places it within the peptide GnRH antagonist family, not among small-molecule receptor inhibitors. Its experimental literature includes animal studies of pituitary gonadotrophin regulation, with non-human primate models contributing information about reproductive endocrine feedback.
A useful distinction in Detirelix experiments is the difference between pituitary responsiveness and the broader endocrine state. A GnRH challenge tests the ability of the pituitary to respond under antagonist exposure, whereas unstimulated hormone measurements also reflect endogenous GnRH pulsatility and gonadal feedback. Sampling schedules therefore matter. Binding potency, inhibition of cellular signalling and changes in circulating hormones should be reported separately rather than treated as interchangeable measures of antagonist activity.
Laboratory notes
- Verify analytical identity with mass spectrometry and chromatographic purity; these tests alone do not fully establish residue stereochemistry.
- Use matched buffer controls and check for peptide precipitation or loss during assay preparation.
- In pulsatile endocrine experiments, standardise sampling intervals and report the relationship between sampling and GnRH challenge.
Storage and reconstitution basics: storage guide.
Questions about Detirelix
Is Detirelix a small molecule?
No. It is a synthetic decapeptide analogue of GnRH with modifications that produce receptor antagonism.
Why are non-human primate models relevant to its research history?
Such models have been used to examine GnRH antagonism within an intact reproductive endocrine feedback system.
Can a single luteinising hormone measurement quantify antagonism?
Not reliably on its own. Pulsatile secretion, feedback and sampling time can affect the measurement independently of receptor occupancy.
Is Detirelix for human use?
No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.
Related research peptides
All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.